{"name":"Brii Biosciences Limited","slug":"brii-biosciences-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"BRII-296","genericName":"BRII-296","slug":"brii-296","indication":"Treatment of COVID-19","status":"phase_2"},{"name":"BRII-835","genericName":"BRII-835","slug":"brii-835","indication":"Treatment of COVID-19","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BRII-179","genericName":"BRII-179","slug":"brii-179","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BRII-179","genericName":"BRII-179","slug":"brii-179","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"BRII-296","genericName":"BRII-296","slug":"brii-296","phase":"phase_2","mechanism":"BRII-296 is a monoclonal antibody that targets the SARS-CoV-2 spike protein.","indications":["Treatment of COVID-19"],"catalyst":""},{"name":"BRII-835","genericName":"BRII-835","slug":"brii-835","phase":"phase_2","mechanism":"BRII-835 is a monoclonal antibody that targets the SARS-CoV-2 spike protein.","indications":["Treatment of COVID-19"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNdUVtX2dCNV9qWHV5d25NcnBsYVFKU1J4SThBTUtGZ2t6dzg4SXVLc1g4UTRKS2g4bmN2XzJaSFJlZDN2MGxYeXl4T05reUVIVkEyOE9FVEFpeTliTk1GX0xiZDJRWW9QM1pwMzd6bEV4RzE3YWItMEZ5Tk5MSDNQZw?oc=5","date":"2025-09-08","type":"deal","source":"Pharmaceutical Technology","summary":"Hengrui Pharma signs deal with Braveheart Bio for HRS-1893 - Pharmaceutical Technology","headline":"Hengrui Pharma signs deal with Braveheart Bio for HRS-1893","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcThhbTlySHFpdFkweWFQVmhSV0RXbi1ZcmF0M2FfWHNuWXhVN0FQam5ETEZVa0FtR0JjaE1uUHlSVHZERm5VZFF6QXpWdHJIRHJfZkYwc05Ld3VCRnQwMDZQZ1ZJbVRmVHB3b3d3cUdab2ZVMHZHMXZOaGFWWHB6YjNpdHlsbzZSSlBOZjZkOGZ6NWtRVUExZ19LendNODZBX2t2MEFRMjRzYW9GejQwdEdJbFNMWFp2VmQ2NzgyYTRyUHdkdjFYTHVGdU53R0pLdnRNaGt5T0NxVVlKcGJTSg?oc=5","date":"2025-08-21","type":"pipeline","source":"PR Newswire","summary":"Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results - PR Newswire","headline":"Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOdGtXdWY2MFBubTRfcUpZZ2xiMmEyWU1PZWczMFdOSzJLQmtSLUpPbk10Zlo1Rk9nUk12TGxSMWJrRDJzSXV1ejB2UWxSQkZzQkJuSUVUaEExRHdwQW1qdUZ3OVAtWU84N1FvVENNRlZ5SU01WlhGdlc4R1JHc0ZNTXBNelg3cWhJVkt1T2d1SkZCNzg?oc=5","date":"2025-07-04","type":"pipeline","source":"Pharmaceutical Technology","summary":"Brii and Joincare Group sign licence agreement for BRII-693 - Pharmaceutical Technology","headline":"Brii and Joincare Group sign licence agreement for BRII-693","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQVzF6QldwTWYwSzFHRkVRU0pmd3dndmgteU5VemdJdjIyZWlheVRXN0F6VVdVWWRrc2xMSjBoelRRVVhQSmJET05raFpQRHkyenRXYWRTdGg3RUx5dGJWaG9tdHZIYWFicnRyeEM4SkFQZ3BGOVNmS1N2b29ZVldQUVdwWGltWnNVUjN5dkpCZDd6YkZqc3BUdnJWOGNLdzhaeFFqTWptb2RrWlN5U1I4eEJaNE8xRUdPTDFqT25Ja2V0ckl4TnFnV2ltNFdYc3h0OUdJdzdFNk1TU0lSWXlyWWhSMGdMN0x3MkhuRUFDLTFCb3pp?oc=5","date":"2025-07-03","type":"pipeline","source":"PR Newswire","summary":"Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China - PR Newswire","headline":"Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNeDhCdTVRazRCQlhEQkhrUjlvU04yYmpxdjFIUk9ZVTM4Yy13RzNVRGhGV2tXX2RoZ0pmMW9tamk4QjZKZGtPc1ZyNDluTncxbTMydUtIcG5YU2FpMXJRbHI4RXZweW1NUS1abGZhLU42TXlhcE5lVTQzcXhhdE1oWXpIMjlqbVcwRDVMN0FMX2JLTFluakxwNmhSaFU1Tk95SThldlcwalhLbTB0cmxXZk93b0NyakhWY1ZyT1M4U05TSmtZWGthVjhuNlBOVmFfY0RzdnU3RmlZLTQ?oc=5","date":"2025-03-21","type":"pipeline","source":"PR Newswire","summary":"Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results - PR Newswire","headline":"Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVWhxSmhZc0V3TExZLTVTbkxFTGY3aU5lSWgwcUYtLWNiRllNenhmeUw5el90enBmaW43amFJQTVWRnlJUGV6ejUyeE96THJLOHM1TEM5UW8xSTVLQkl2V3c3djZkbThLYkttT0N4Q1RZdkxhMTNhSFhjOGttVzF4aWFwZ3Z5a0dVOHVaS1hPRUFsOGVzeVJaQkZRYWZ3b0h2ZG50RnNleWxUdw?oc=5","date":"2025-01-03","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Roche, Innovent's ADC deal; Lessons from AZ's China probes; Viatris' warning letter - Fierce Pharma","headline":"Fierce Pharma Asia—Roche, Innovent's ADC deal; Lessons from AZ's China probes; Viatris' warning letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPd244aGU2OERReVJxUlBpWVJhSGdvaXRpVlhHZzhuNDloSXcwUGpUWS01WjlRVUYyX1lYSXJhcmV1VTlJWGJTN0VybEF6elF0SlNaR3RDRUlPTnNGWE9iUFY1ZVExTTBneDlydWxMRGRCN0lXWWNHOEVvbnRVVUVJQzBUcVJqWWNibXhUUlc2VzhuZzdVVUUyenNKZThLVjBybE0wY0taWnV6UzVQSWttQlp4LTF3bUVMZTJxa29Ma0d1THRYU2c?oc=5","date":"2024-08-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals - Pharmaceutical Technology","headline":"Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPcml0OHNkQlFESlMzOVRvc3hzcVlESTRRd1I3Yi1tOG5pZDAxY09NZjNSMkFpYTI1eG5iVVRTcnJOZUM2dFdTbHdhR1pqOW9Rai13OFR1VUduWmJkUnJFejc2dkl3NDFnQkFVMWhKWWVUbUpnUlg2V054RUNReWcxSHVfM0I4bFBQckllUVRoekJ0MGc?oc=5","date":"2023-07-11","type":"pipeline","source":"BioCentury","summary":"Billy Cho joins CBC as senior managing director - BioCentury","headline":"Billy Cho joins CBC as senior managing director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPRWhMOHRCR3pfYWJDcVZ3SDlwZ0kzT3FERkhYZk80VjVRQTF2V194ZlhaUS1ZcU5jR053UUtjdWx5c0hUbFBVcDNfTTdONUhKaW5JVDcxN1NjdU91V2QzTXo5cm9ZRmVib1JIRWFZeGgzeVp3UHdEV0tiZHFKY1FoMHNBYVRvYWlDbHBIUHlyakZKMjA?oc=5","date":"2023-07-06","type":"deal","source":"BioPharma Dive","summary":"Brii buys further into VBI therapy, expanding hepatitis B partnership - BioPharma Dive","headline":"Brii buys further into VBI therapy, expanding hepatitis B partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQU0xOUGJmbnVlMnFNTHBQVHdYUVZlMGhMT2pYdmp4VTBwYWM3d0hwLWdZaXdNc2JoZjI0WE9BSjJCMHBGbnhhX253Z0Vrd0xiUXRUV01uV2JqNmt4YjRzZGhTVVJ3M3k5eUFjcWV3M3pGR0Q1ZWUtSF9hRVNJVFVkSWt0a3k1TktUUHhfZ2ZOMVVmTGF6Z2o1ZlZXSi0?oc=5","date":"2021-12-13","type":"pipeline","source":"The Standard (HK)","summary":"Pharma firm's cocktail works against Omicron - The Standard (HK)","headline":"Pharma firm's cocktail works against Omicron - The Standard (HK)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE53ZDY1VWtZUnF1MnNpSWJqS0xnOXJ5SjhtQXI2a2Y1blVRb3hVUS0yRk9hWDlxM1FQaVE4andPenNNQmNpb0Y4QVBraE9TbXgzVFFkOTZR?oc=5","date":"2021-07-28","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Keymed Biosciences Inc. (2162.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Keymed Biosciences Inc. (2162.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPUmc2VTRSczJVSTFBRlNDOTVTRks3S1AyR3dYd05BdzVlUVVkQ3ZqY3hDZXJPVTNEMmxZMnlwSXpXUG9GRTRGX3lINEFUNVZwOUhJS0pUdG9raXJDWWRkWmN1ZjdqQ0V4S09oRGNTNjdvUDVZZ2NBdldlMmMyYVNJQ3JUWVRTLTJaa2g1TUhB?oc=5","date":"2018-05-24","type":"pipeline","source":"Fierce Biotech","summary":"GlaxoSmithKline veteran Zhi Hong launches Brii Biosciences with $260M - Fierce Biotech","headline":"GlaxoSmithKline veteran Zhi Hong launches Brii Biosciences with $260M","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}